AIBioTech

About:

AIBioTech is a contract research organization providing R&D and clinical testing services to institutions and government agencies.

Website: http://www.aibiotech.com/Home.aspx

Twitter/X: AIBioTech

Top Investors: PULSAR

Description:

AIBioTech provides drug discovery and diagnostic development organizations a broad range of world-class laboratory services to bring new products to market. Located in a 32,000 square foot laboratory in Richmond, Virginia, AIBioTech is one of the world's most comprehensive Contract Research Organizations in operation. AIBioTech provides reliable expertise and cutting-edge technologies which are not available from other companies. An expert core laboratory, we provide consultation on experimental design and offer comprehensive services under GLP and non-GLP compliance. These services are offered individually or can be integrated to support product development from discovery-to-market with full Regulatory Support under FDA GLP Guidelines 21 CFR 58. AIBioTech provides the following capabilities to clients: Molecular biology Protein expression & analysis and peptide synthesis & purification Bio-analytical services (CLIA certified) Assay development and validation Microbiology, virology & biosafety testing (BSL3 facilities) Program expertise

Total Funding Amount:

$1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Richmond, Virginia, United States

Founded Date:

1992-01-01

Contact Email:

aibiotech(AT)gmail.com

Founders:

David Bostwick, Thomas Reynolds

Number of Employees:

51-100

Last Funding Date:

2016-11-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai